Panel Discussion | CMD - What Is Next?

Sunday, March 8, 2026

11:12 AM - 11:45 AM EST

Location: Lincoln

Moderator(s)

Shrilla Banerjee, MD FRCP FESC

Consultant Interventional Cardiologist
Surrey and Sussex Healthcare NHS Trust
Redhill, England, United Kingdom

Disclosure information not submitted.
Nathaniel R. Smilowitz, MD

Assistant Professor of Medicine
NYU Langone Health
New York, New York, United States

Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AngioInsight: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)
Pieter C. Smits, PhD, FESC

Chief Medical Director
CERC (Cardiovascular European Research Center)
Rotterdam, Zuid-Holland, Netherlands

Disclosure information not submitted.

Panel Discussant(s)

Brian C. Case, MD

Interventional Cardiologist; Assistant Professor of Medicine, Georgetown University; Director of Cath Lab, Chief of Interventional Cardiology, MedStar Southern Maryland Hospital
MedStar Heart and Vascular Institute
Bethesda, Maryland, United States

Disclosure(s): Acist Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Timothy D. Henry, MD

Director, The Carl and Edyth Lindner Center for Research and Education
The Christ Hospital
Bellevue, Kentucky, United States

Disclosure(s): No financial relationships to disclose
Amir Lerman, MD

Consultant
Mayo Clinic
Rochester, Minnesota, United States

Disclosure(s): Philips: Consulting Fees (e.g., advisory boards) (Ongoing)
Jean-Michel Paradis, MD

Structural and Interventional Cardiologist
Quebec Heart and Lung Institute
Quebec, Quebec, Canada

Disclosure(s): No financial relationships to disclose
Ramon Quesada, MD, FACP, FACC, FSCAI

Medical Director of Interventional Cardiology, Structural Heart & Cardiac Research
Miami Cardiac & Vascular Institute
Miami, Florida, United States

Disclosure(s): No financial relationships to disclose
Robert S. Schwartz, MD, FACC, FSCAI

President
DeHaan Center for Medical Innovation
Longboat Key, Florida, United States

Disclosure(s): Autonomix LLC: Employee (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)
Janet Wei, MD

Associate Professor, Cardiology and Biomedical Sciences
Cedars-Sinai Smidt Heart Institute

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Nathaniel R. Smilowitz, MD: Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AngioInsight: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)

Brian C. Case, MD: Acist Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Timothy D. Henry, MD: No financial relationships to disclose

Amir Lerman, MD: Philips: Consulting Fees (e.g., advisory boards) (Ongoing)

Jean-Michel Paradis, MD: No financial relationships to disclose

Ramon Quesada, MD, FACP, FACC, FSCAI: No financial relationships to disclose

Robert S. Schwartz, MD, FACC, FSCAI: Autonomix LLC: Employee (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Janet Wei, MD: No financial relationships to disclose